Stem Cells and β&lgr;&agr;σ&tgr;η&mgr;a Cells

Publisher： Bentham Science Publishers

E-ISSN： 2212-3946|3|1|53-54

ISSN： 1574-888X

Source： Current Stem Cell Research & Therapy, Vol.3, Iss.1, 2008-01, pp. : 53-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sources of &bgr;-Cells for Cell Therapy in Diabetes

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 6, Iss. 2, 2006-04 ,pp. : 219-231

Bentham Science Publishers

Access to resources Recommend Favorite

Mesenchymal Cells in the Treatment of Spinal Cord Injury: Current & Future Perspectives

By  

Current Stem Cell Research & Therapy, Vol. 8, Iss. 1, 2013-01 ,pp. : 25-38

Bentham Science Publishers

Access to resources Recommend Favorite

cAMP Signalling in the Kinetoplastid Protozoa

By  

Current Molecular Medicine, Vol. 4, Iss. 6, 2004-09 ,pp. : 585-599

Bentham Science Publishers

Access to resources Recommend Favorite

&ggr;-Secretase-Regulated Signaling Pathways, such as Notch Signaling, Mediate the Differentiation of Hematopoietic Stem Cells, Development of the Immune System, and Peripheral Immune Responses

By  

Current Stem Cell Research & Therapy, Vol. 6, Iss. 2, 2011-06 ,pp. : 131-141

Bentham Science Publishers

Access to resources Recommend Favorite

Ubiquitin-like polypeptide inhibits cAMP-induced p38 MAPK activation in Th2 cells

By Nakamura Morihiko   Tanigawa Yoshinori  

Immunobiology, Vol. 208, Iss. 5, 2004-03 ,pp. : 439-444

Urban & Fischer

Access to resources Recommend Favorite